A detailed history of Schonfeld Strategic Advisors LLC transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 68,243 shares of ITOS stock, worth $501,586. This represents 0.01% of its overall portfolio holdings.

Number of Shares
68,243
Holding current value
$501,586
% of portfolio
0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.09 - $17.97 $688,571 - $1.23 Million
68,243 New
68,243 $696,000
Q2 2022

Aug 15, 2022

BUY
$16.57 - $35.1 $406,660 - $861,424
24,542 Added 91.27%
51,430 $1.06 Million
Q1 2022

May 16, 2022

BUY
$31.92 - $47.45 $858,264 - $1.28 Million
26,888 New
26,888 $865,000

Others Institutions Holding ITOS

About iTeos Therapeutics, Inc.


  • Ticker ITOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,575,300
  • Market Cap $261M
  • Description
  • Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...
More about ITOS
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.